Moderna (MRNA) stock news

Moderna (MRNA) stock news. Deduplicated factual headlines, scored for importance, with entity sentiment and the sectors, countries, and asset classes affected. Updates open into the storyline.

See the full wire

20 wire items

2026-10-30 11:00:00 UTC#545165newforecastnews

Moderna (MRNA) Q3 2026 earnings preview: $890.25M revenue and ($1.10) EPS expected

tradingviewimportance 0.40trust 0.70Moderna, Inc. 0

2026-10-28 15:54:07 UTC#530275newconfirmednews

CheddarFlow reports $2M+ in Moderna (MRNA) call options bought for $250 strike expiring next week

cheddarflowimportance 0.30trust 0.50Moderna, Inc. +0.20

2026-10-27 16:59:00 UTC#522950newconfirmedanalysis

Moderna CEO Stéphane Bancel discusses leadership style and corporate culture in profile piece

dow_jonesimportance 0.30trust 0.80Moderna, Inc. 0Stéphane Bancel 0

2026-10-27 14:20:20 UTC#522021duplicateconfirmednews

Moderna shares decline following William Blair downgrade on valuation concerns

seeking alphaimportance 0.30trust 0.70Moderna, Inc. -0.40William Blair & Company, L.L.C. -0.30

2026-10-27 13:19:38 UTC#521626newconfirmednews

Moderna downgraded to Market Perform at William Blair on valuation concerns following 545% YTD rally

yahooimportance 0.50trust 0.70Moderna, Inc. -0.40William Blair & Company, L.L.C. -0.40Merck & Co., Inc. 0+2 entities

2026-10-26 22:22:00 UTC#517785updateconfirmednews

Moderna CEO Bancel defends cancer vaccine intismeran as blockbuster despite recent stock volatility

dow_jonesimportance 0.40trust 0.80Moderna, Inc. +0.40Stéphane Bancel +0.40Merck & Co., Inc. +0.20+2 entities

2026-10-26 21:27:44 UTC#517532updateconfirmednews

Moderna CEO Bancel cites 42% improvement over Keytruda in cancer vaccine study, eyes 2027 FDA filing

bloombergimportance 0.60trust 0.80Moderna, Inc. +0.60Merck & Co., Inc. +0.50Stéphane Bancel +0.40+2 entities

2026-10-26 20:36:25 UTC#517221duplicatereportednews

Moderna CEO Bancel reiterates potential for cancer vaccine to treat multiple tumor types

seeking alphaimportance 0.30trust 0.60Moderna, Inc. +0.30Stéphane Bancel +0.30

2026-10-26 19:59:33 UTC#516952newconfirmednews

Moderna CEO Bancel expects mRNA cancer vaccine to show efficacy across multiple tumor types

bloombergimportance 0.40trust 0.90Moderna, Inc. +0.30Merck & Co., Inc. +0.20Stéphane Bancel +0.10

2026-10-26 14:52:00 UTC#515500updateconfirmedanalysis

Moderna cancer vaccine intismeran receives lukewarm ESMO reception, Citi analyst notes

dow_jonesimportance 0.40trust 0.80Moderna, Inc. -0.40Merck & Co., Inc. -0.20Amgen Inc. +0.40+2 entities

2026-10-26 13:50:00 UTC#515125newconfirmedanalysis

Investor enthusiasm for Moderna's experimental cancer vaccine wanes amid high expectations

marketwatchimportance 0.40trust 0.70Moderna, Inc. -0.40

2026-10-26 12:57:19 UTC#514784newconfirmednews

Merck and Moderna report positive Phase 3 results for mRNA cancer therapy in INTerpath-001 trial

financial postimportance 0.60trust 0.80Merck & Co., Inc. +0.50Moderna, Inc. +0.50INTerpath-001 +0.50

2026-10-26 10:36:37 UTC#513885updateconfirmednews

Moderna shares fall another 9.3% in premarket trading, extending losses to over 25% in three sessions

walter_bloombergimportance 0.40trust 0.60Moderna, Inc. -0.60

2026-10-25 18:56:45 UTC#511629newreportednews

Moderna shares drop 22% following influencer put activity; $5B SPY put wall noted at 760 strike

cheddarflowimportance 0.50trust 0.30Moderna, Inc. -0.80SPDR S&P 500 ETF Trust -0.20

2026-10-24 09:30:00 UTC#510005updateconfirmedanalysis

Moderna stock valuation remains stretched despite recent sell-off, WSJ analysis suggests

wsjimportance 0.40trust 0.80Moderna, Inc. -0.40

2026-10-24 09:30:00 UTC#510003updateconfirmedanalysis

Moderna stock faces continued volatility as market recalibrates expectations following cancer vaccine data, WSJ analysis says

dow_jonesimportance 0.40trust 0.80Moderna, Inc. -0.40Merck & Co., Inc. +0.20Melanoma 0

2026-10-24 07:17:16 UTC#509853newconfirmedanalysis